TSVT
Companies
NASDAQ
2Seventy Bio Inc.
Health Care
$5.00
+$2.06 (+70.07%)
Price Chart
Overview
About TSVT
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Market Cap
$201.3M
Volume
3.0M
Avg. Volume
4.6M
P/E Ratio
-11.627907
Dividend Yield
0.00%
Employees
269.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.29
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TSVT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$201.3M
Volume3.0M
P/E Ratio-11.63
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 7, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025